Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 248-259)

MR NIGEL EDWARDS, MR DAVID STOUT AND DR BRIAN FISHER

22 FEBRUARY 2007

  Q248 Chairman: Good morning, gentlemen. Could you introduce yourselves?

  Dr Fisher: I am a GP in south east London and I am PPI lead for the NHS Alliance.

  Mr Edwards: I am director of policy for the NHS Confederation, the membership organisation for the organisations that make up the NHS, including voluntary and independent sector providers.

  Mr Stout: I am the PCT Network director within the NHS Confederation, providing a network of all the PCTs across the country. I should say that I am four days into the job. Previously I was chief executive of Newham Primary Care Trust in East London, where I was chief executive for the last six years.

  Q249  Chairman: A question to all of you: do you think clinicians and managers take PPI seriously enough?

  Dr Fisher: I think their intentions are good. They would like to; they see the importance of it. Over the last 10 years or so in the NHS it has become clear that clinicians are hearing much more clearly what local people are saying to them, but I think their remains a real deficit in clinicians and managers responding to what local people are saying to them, so listening has improved but responding to that has not improved and there is evidence for that.

  Mr Edwards: I would endorse that and have not very much to add to that, to be honest.

  Mr Stout: I would also agree. From a commissioning perspective which, from a PCT end of things, I should probably focus on, PPI is fundamentally about doing the job properly. Do we always get it right? No. We know we need to improve.

  Q250  Chairman: How far do you think it is their fault and how far is it a reflection on the work done by the local PPIs? Do you think they do take it seriously in some parts of the NHS as opposed to others?

  Dr Fisher: It is very variable. There are some areas and some sectors that have done fantastic work, and you have heard some of them already, but it is very patchy. I would not say it is the clinician's fault exactly but it is quite scary, actually, both being a clinician listening to what local people are saying and being a manager listening to what they are saying. It is not an easy process and it threatens one's control, one's power, and I do not think it is recognised how delicate a process that can be. So it is a challenge, it needs to be managed, and clinicians need to be supported to understand and respond to it.

  Mr Edwards: One of the issues about this whole policy area that has been of some concern to us is the tendency to confuse two related, but quite different sets of functions. One involving patients in talking about their experience and how we can improve that and make it better, and talking to the public, which may be more about the overall design of services, the setting of priorities, perhaps a more general set of questions. They require quite different mechanisms and have quite a different focus. There has been a bit of a tendency in the way that policy and machinery has been constructed to confuse those two. The public, if they are not currently using the health services, may be quite difficult to engage because they have other parts of their lives to be getting on with. Those of us who work in health services may think it is most important but members of the public are interested in a whole range of other functions, and different mechanisms need to be found. Both in policy terms and sometimes in terms of mechanics we have not been clever enough about devising the mechanisms that particularly target the right group for the question we are trying to answer.

  Mr Stout: That is absolutely right, and there is also a distinction between patient and public involvement in providing services and the patient and public involvement required for commissioning services and, again, there are some distinctions on how that could and should operate. Historically, perhaps, we have rather muddled those up and not made those distinctions as clear as they might be.

  Q251  Chairman: At a previous inquiry session, Dr Day from the Harrogate Foundation Trust told us that PPI must offer: "very reliable data which is replicated and which is reliable and not anecdotal and certainly not one of the loud voices being heard exclusively". Do you agree? Do PPIs provide this?

  Dr Fisher: I agree that the data on which recommendations from local people are made should be as robust as possible. There are lots of different ways of getting that information; there is a huge amount of national and international data on things that patients would like in general; the Picker Institute delivers a lot of information about that, for instance. There are lots of surveys that have been done in similar populations to the ones in one's own PCT. So there is quite a lot of robust general information on which you can base decisions. If you are talking about very local issues with one particular hospital or cluster it is much more difficult, and this issue of representativeness is really difficult. I would suggest that getting representative information from local people is a chimera, really. I do not think it is possible to get it. You have to work on the best data you have which I have to say is what we do a lot in any case in clinical areas. If you are listening to what GPs have to say, for instance, you are not necessarily getting a representative sample. But it is really important not just to listen to the loudest voices, and there are simple ways of making sure those are not the only voices you hear.

  Q252  Chairman: You did say that you should have the data and the data is available, but the real question is do they, in practice and in your experience, have the data as opposed to it being available and they should have it?

  Dr Fisher: Yes, it is available. A good PPI forum or a PPI part of the PCT should be able to get that within 15 minutes. It is not difficult to get it. The King's Fund will provide it; lots of places will provide the data. Again, even if you provide it you could provide a very efficient set of information to the PCT. But I would like to make a point about practice-based commissioning in that you might be able to provide to the practice-based commissioning group but at this point there is no onus on them necessarily to have to do anything about it. The data is important, but however good the data is there is still another question about whether people respond and whether they are in any sense accountable.

  Mr Edwards: I would agree with that point of view. You might well use anecdotes to inform hypotheses that you then go and test and collect the data. It would be probably unwise to discount all useful anecdotal evidence. It can be a very useful source. If it is all you rely on, however, you are likely to run into quite severe difficulties and you should then perhaps go and test this. And it may be that some of these anecdotes and stories that you pick up may point you in directions that are well worth investigating, even though you may find there is nothing there.

  Q253  Chairman: Do you think you have seen evidence where PPI has used data as opposed to could use data?

  Mr Edwards: We certainly heard evidence from the previous witnesses. I think there are some issues about the rigour you need to do the sorts of studies, such as the quite impressive sounding one we heard described, which are methodologically demanding as well as having some quite significant resource implications but, if these are important questions that either providers or commissioners should be asking, then it might well be that if there is an issue about, for example, waiting times in a genitor-urinary medicine clinic and the need to go and find user opinion, a commissioner or provider that was presented with some early signs that there was an issue would be well advised to go out and research that properly themselves, maybe through helping the patient's forum or the PPI machinery to do that.

  Mr Stout: We need to be clear who is responsible for what. To expect PPI forums or LINks to do everything that your question suggested I think is a little unrealistic. To expect PCTs and commissioning services, as Nigel says, to undertake effective review of data and get hold of information having been alerted to a problem by a PPI forum or a LINks is entirely reasonable. On the other hand, getting down to a very local scale and talking about PPI in the sense of "I am a patient; you are my clinician", then my anecdote is important. You want the patient/clinician relationship to be absolutely based on anecdote; you want big commissioning decisions to be influenced by the stories you hear and then followed through with a slightly more robust objective assessment. We are in danger of doing what we said earlier and seeing PPI as one thing when it is many things.

  Dr Fisher: There are data crunchers that should be available to LINks or PPI forums. Public health in the PCT, I understand—and I still have not quite grasped all the bits of LINks—that the local authority should be providing statistical support and so on, so there are people around to do it.

  Q254  Chairman: Do you understand LINks? Is it more than a concept in your view? You mentioned it together in passing there between PPI and LINks.

  Dr Fisher: Yes, I think it is. I suppose the way I feel about it is that I can see what is required; I can see the functions that need to be performed; and I can see how they ought to be performed. What the name or the title is for this I am not really bothered, but there are serious characteristics of a good patient and public involvement service that LINks could have a good handle on if it is resourced adequately and supported adequately.

  Q255  Chairman: And presumably has the ability to get the data and everything—

  Dr Fisher: Obviously that is the easiest bit. The data, I think, is the easiest.

  Q256  Chairman: Do you understand this, Nigel? Do you think this is a read-over in terms of what PPIs are doing now as opposed to what LINks will be doing at some stage in the future?

  Mr Edwards: Perhaps I can respond to that in a couple of ways. When you read the guidance on LINks there are some interesting questions about governance and leadership and how they are going to operate and exactly what they are going to do, but we have taken the view that public and patient involvement is now such a key part of what both commissioners and providers have to be doing that what we should be judging them on is the effectiveness of how they do that rather than their compliance to a particular structure and model. People should be able to develop appropriate mechanisms, because what may be appropriate in, for example, David's old patch in Newham may be very different from what you might want to do in a rural county council such as Norfolk, which we heard about earlier, so people need to be held to account for the effectiveness of what they do, and not just their compliance with structural arrangements. There is one other point which is worth making, which is that while LINks are commissioner-focused and local authority-focused and we would absolutely support that and it is in line with the way that much of the healthcare reform is going, hospitals and other providers are not going to stop doing public and patient involvement. It would be extremely foolish of a trust to say, like the Bristol one we just heard about, "I have an effective mechanism for engaging the public and I am now going to dispense with it because there has been some other change in some other part of the forest". The other point that is really important to make is that, as the number of foundation trusts grow, there is built into their governance the mechanism of governors and members, and we have all been very taken by how foundation trusts, their governors and members have really taken that model. Perhaps to some extent to a level of involvement and engagement that was not fully anticipated by some of us when the policy was first introduced. So there are other dynamics as this process is evolving other than just the LINks. The LINks potentially could add some real value to that by providing over-arching structure and some input into commissioning but there are all of these other mechanisms too and we need to be encouraging providers and using methods like the Healthcare Commission standards and their inspection process to ensure that people are being able to demonstrate that they are fully engaging their local public and their patients.

  Mr Stout: The direction of travel with LINks seems reasonably clear and has clearly been evolving over time and I think sensibly evolving. There seems to be an effective dialogue that says that when LINks started as an idea it was pretty vague but I have to say it has become quite a lot clearer to me over the last few months and the direction of travel seems right. Clearly some of the devil is in the detail and the specification for what LINks has to do is pretty critical. I absolutely agree with Nigel and I do not think that specification should be saying how to do it, but what should be clear to the local authority commissioning the host organisation is what it is they are supposed to be commissioning? What is the output we are trying to get out of this? The more that is defined clearly, the more effective LINks are likely to be. But on direction of travel I think I am reasonably clear where it is going.

  Q257  Chairman: Nigel, you mentioned Bristol. It was mentioned earlier about the funding of the forum and the question of independence, whether it was funded by the hospital trust itself or by some other body. What is your personal perception of that? What do you think the public's perception of that would be?

  Mr Edwards: It might be worth distinguishing between foundation trusts, who have patient involvement at the heart of their governance, and non foundation trusts, of which there will be an increasingly shrinking number, of course. Foundation trusts, I guess, have to treat their members and governors as sovereign. In other words, they have to respect their independence.

  Q258  Chairman: Yes. This is not a foundation trust. Therefore there is a question now about if a change takes place now in terms of who is supporting and resourcing and funding that particular forum, if that is not on offer in a few months' time, is there a question mark about its independence or, indeed, the public perception of its independence if it becomes supported and resourced by the trust itself as opposed to some other organisation?

  Mr Edwards: That is an interesting question. I am not sure to what extent the public are aware of how these organisations are currently funded. They are, of course, still funded from the Department of Health. I think I am back to my "by their acts shall ye know them" philosophy here which is that you will be able to tell whether these organisations have some form of independent voice from the way they behave. There is clearly an issue, if I am a trust and I have a patients' forum which I am funding, I think it is hard to present it as independent, but if I want it to be effective and if I do not treat it as though it has the ability to challenge me to make statements which may not be awfully comfortable, then I suspect that what we will find is that people will vote with their feet, and you will very quickly not have an effective patient involvement mechanism. So, we are a bit short on cast iron guarantees of independence, I will give you that, but in terms of the imperative for organisations now to make really sure of the growth of choice and so on and much more local scrutiny and accountability, you would be very foolish not to have a system which allows you to get a clear independent voice in addition to LINks perhaps within your own organisation.

  Q259  Sandra Gidley: The PPI forums are supposed to offer a unique patient perspective but many of them have found themselves dealing with issues such as hospital cleanliness, infection control and feeding patients. Is that not really using PPI as a substitute for good clinical governance?

  Mr Edwards: If you look at the sort of polling that Angela Coulter has done and MORI have done on patient experience, the sorts of things that come very high up the list as important to patients, as I am sure you will all be aware, are precisely some of those issues. You failed to mention car parking which is one of the other ones that frequently comes up.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2007
Prepared 20 April 2007